跳至主要内容
临床试验/EUCTR2021-000182-33-NL
EUCTR2021-000182-33-NL进行中(未招募)1 期

Effect of Bacillus Calmette-Guérin vaccination on the immunogenicity of the mRNA BNT162b2 COVID-19 vaccine in health care workers - COMBI study

Radboudumc0 个研究点目标入组 40 人开始时间: 2021年1月21日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Radboudumc
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age equal to or above 18 years;
  • - Written informed consent provided by the participant;
  • - Receiving BioNTech/Pfizer COVID-19 vaccine per routine care;
  • - Having received BCG-vaccination in the past 12 months OR never having received BCG-vaccination.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Legally incapacitated or unwilling to provide informed consent;
  • - History of COVID-19 infection, confirmed by a microbiological test.

研究者

发起方
Radboudumc

相似试验